Mieke Kriege

6.9k total citations · 1 hit paper
32 papers, 2.4k citations indexed

About

Mieke Kriege is a scholar working on Genetics, Cancer Research and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mieke Kriege has authored 32 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Genetics, 13 papers in Cancer Research and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mieke Kriege's work include BRCA gene mutations in cancer (25 papers), Cancer Genomics and Diagnostics (11 papers) and Radiomics and Machine Learning in Medical Imaging (7 papers). Mieke Kriege is often cited by papers focused on BRCA gene mutations in cancer (25 papers), Cancer Genomics and Diagnostics (11 papers) and Radiomics and Machine Learning in Medical Imaging (7 papers). Mieke Kriege collaborates with scholars based in Netherlands and United States. Mieke Kriege's co-authors include Cecile T.M. Brekelmans, Madeleine M.A. Tilanus‐Linthorst, Harmine M. Zonderland, Jan G.M. Klijn, Harry J. de Koning, C. Boetes, Emiel J. Rutgers, Jan C. Oosterwijk, Rob A.�E.�M. Tollenaar and Inge Marie Obdeijn and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

Mieke Kriege

30 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition

2004 1.2k citations Mieke Kriege, Cecile T.M. Brekelmans et al. New England Journal of Medicine profile →

Peers

Mieke Kriege

GENET

ONCOL

PFM

RNMI

Madeleine M.A. Tilanus‐Linthorst Netherlands

Cecile T.M. Brekelmans Netherlands

Inge Marie Obdeijn Netherlands

S.E. Harms United States

Yaffe Mj Canada

Petrina A. Causer Canada

Rene Shumak Canada

Doo Ho Choi South Korea

A Nerurkar United Kingdom

Ichiro Maeda Japan

Madeleine M.A. Tilanus‐Linthorst Netherlands

Mieke Kriege

1.8k ×1.6

GENET

1.3k ×1.4

ONCOL

1.5k ×1.8

1.2k ×1.7

PFM

1.1k ×1.6

RNMI

Citations per year, relative to Mieke Kriege Mieke Kriege (= 1×) peers Madeleine M.A. Tilanus‐Linthorst

Countries citing papers authored by Mieke Kriege

Since Specialization

Citations

This map shows the geographic impact of Mieke Kriege's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mieke Kriege with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mieke Kriege more than expected).

Fields of papers citing papers by Mieke Kriege

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mieke Kriege. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mieke Kriege. The network helps show where Mieke Kriege may publish in the future.

Co-authorship network of co-authors of Mieke Kriege

This figure shows the co-authorship network connecting the top 25 collaborators of Mieke Kriege. A scholar is included among the top collaborators of Mieke Kriege based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mieke Kriege. Mieke Kriege is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brinton, John T., R. Edward Hendrick, Brandy M. Ringham, Mieke Kriege, & Deborah H. Glueck. (2019). Improving the diagnostic accuracy of a stratified screening strategy by identifying the optimal risk cutoff. Cancer Causes & Control. 30(10). 1145–1155. 4 indexed citations

Hout, Annemieke van der, Jan C. Oosterwijk, Janet R. Vos, et al.. (2018). The association between cancer family history and ovarian cancer risk in BRCA1/2 mutation carriers: can it be explained by the mutation position?. European Journal of Human Genetics. 26(6). 848–857. 6 indexed citations

Doorn, Helena C. van, Marian J.E. Mourits, Marc van Beurden, et al.. (2016). Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers. British Journal of Cancer. 115(10). 1174–1178. 3 indexed citations

Kriege, Mieke, Antoinette Hollestelle, Agnes Jager, et al.. (2014). Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy. British Journal of Cancer. 111(5). 1004–1013. 49 indexed citations

Vencken, P.M.L.H., Welmoed Reitsma, Mieke Kriege, et al.. (2013). Outcome of BRCA1- compared with BRCA2-associated ovarian cancer: a nationwide study in the Netherlands. Annals of Oncology. 24(8). 2036–2042. 16 indexed citations

Vencken, P.M.L.H., Mieke Kriege, Maartje J. Hooning, et al.. (2012). The risk of primary and contralateral breast cancer after ovarian cancer in BRCA1/BRCA2 mutation carriers. Cancer. 119(5). 955–962. 30 indexed citations

Kriege, Mieke, Agnes Jager, Maartje J. Hooning, et al.. (2011). The efficacy of taxane chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers. Cancer. 118(4). 899–907. 67 indexed citations

Kriege, Mieke, C. Boetes, Robert A.E.M. Tollenaar, et al.. (2007). Mid-term efficacy of a breast cancer screening program for women with a familial or genetic susceptibility: update of the Dutch MRI screening study (MRISC).. Breast Cancer Research and Treatment. 106. 1 indexed citations

Zonderland, Harmine M., Marinus J.C. Eijkemans, Mieke Kriege, et al.. (2007). Mammography: Interobserver variability in breast density assessment. The Breast. 16(6). 568–576. 100 indexed citations

10.

Kriege, Mieke, Caroline Seynaeve, Hanne Meijers‐Heijboer, et al.. (2007). Distant disease-free interval, site of first relapse and post-relapse survival in BRCA1- and BRCA2-associated compared to sporadic breast cancer patients. Breast Cancer Research and Treatment. 111(2). 303–311. 25 indexed citations

11.

Brekelmans, Cecile T.M., Madeleine M.A. Tilanus‐Linthorst, Caroline Seynaeve, et al.. (2007). Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases. European Journal of Cancer. 43(5). 867–876. 158 indexed citations

12.

Kriege, Mieke, Cecile T.M. Brekelmans, C. Boetes, et al.. (2006). Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition. Cancer. 106(11). 2318–2326. 68 indexed citations

13.

Kriege, Mieke, Cecile T.M. Brekelmans, Inge Marie Obdeijn, et al.. (2006). Factors Affecting Sensitivity and Specificity of Screening Mammography and MRI in Women with an Inherited Risk for Breast Cancer. Breast Cancer Research and Treatment. 100(1). 109–119. 72 indexed citations

14.

Kriege, Mieke, Cecile T.M. Brekelmans, C. Boetes, et al.. (2005). Efficacy of Magnetic Resonance Imaging and Mammography for Breast Cancer Screening in Women With a Familial or Genetic Predisposition. Obstetrical & Gynecological Survey. 60(2). 107–109. 8 indexed citations

15.

Brekelmans, Cecile T.M., Caroline Seynaeve, M. Menke-Pluymers, et al.. (2005). Survival and prognostic factors in BRCA1-associated breast cancer. Annals of Oncology. 17(3). 391–400. 101 indexed citations

16.

Tilanus‐Linthorst, Madeleine M.A., Mieke Kriege, C. Boetes, et al.. (2005). Hereditary breast cancer growth rates and its impact on screening policy. European Journal of Cancer. 41(11). 1610–1617. 58 indexed citations

17.

Wagner, Anja, Mieke Kriege, Carli M.J. Tops, et al.. (2005). Long Term Follow-up of HNPCC Gene Mutation Carriers: Compliance with Screening and Satisfaction with Counseling and Screening Procedures. Familial Cancer. 4(4). 295–300. 71 indexed citations

18.

Kriege, Mieke, Cecile T.M. Brekelmans, C. Boetes, et al.. (2004). Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition. New England Journal of Medicine. 351(5). 427–437. 1211 indexed citations breakdown →

19.

Kriege, Mieke, Cecile T.M. Brekelmans, & Jan G.M. Klijn. (2004). Comment on Screening by MRI Mentioned in the Reviews by Narod and Møller. Hereditary Cancer in Clinical Practice. 2(1). 17–8.

20.

Kriege, Mieke, Cecile T.M. Brekelmans, C. Boetes, et al.. (2003). MRI screening for breast cancer in women with high familial and genetic risk: First results of the Dutch MRI screening study (MRISC).. Journal of Clinical Oncology. 21(23). 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact